ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Peptide-conjugated phosphodiamidate morpholino oligonucleotide (PPMO)-based henipavirus therapeutics
Peptide-conjugated phosphodiamidate morpholino oligonucleotide (PPMO)-based henipavirus therapeutics is a funding opportunity from ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, up to 475339, closing March 31, 2028.
Mar 31, 2028
(609d left)Overview
SUMMARY Nipah virus (NiV) is a highly lethal zoonotic paramyxovirus from the Henipavirus genus that causes severe respiratory disease and encephalitis in humans. To date, no antivirals have been approved for treatment or prevention of these infections. We will develop and test peptide-conjugated phosphorodiamidate…